Full Text
Vedolizumab In Ulcerative Colitis; A Budget Impact Model for A Novel Drug In A Recession Environment

Abstract

Authors

I Petrakis S Koilakou K Masouridou AM Kollia

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×